PBP World Meeting 2026

This year, the 15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology takes place in Prague, Czech Republic.

From 23 to 26 March 2026, this well-established major meeting transforms the Prague Convention Centre into a global hub for pharmaceutical scientists from industry, academia, and regulatory bodies. Alongside the scientific program, the steadily growing ResearchPharm® exhibition provides a cross-disciplinary platform to discover the newest trends in pharmaceutical ingredients, excipients, and processing equipment.

Pharma Excipients gives you an overview of the excipient suppliers and equipment manufacturers:

Antares

📅 Poster Presentation: Overcoming Challenges in the Development of mRNA Therapeutics

📍 Poster Area

ARMOR PHARMA

Armor Pharma is part of the Savencia Group, a world-leading specialty cheese company. Armor Pharma was set up in 2014 after the completion of a purpose-built manufacturing site for pharma-grade lactose. The pharma-lactose plant is based on more than 40 years of manufacturing experience serving the infant formula market with high-quality lactose.

Thanks to exceptional product quality and client service, Armor Pharma is becoming an important actor in the business of pharmaceutical excipients. The manufacturing facility is EXCIPACT (GMP), ISO 9001, and ISO 22000 certified. The Armor Pharma portfolio includes lactose monohydrate, lactose for direct compression, and lactose for dry powder inhalation (DPI).

📅 Session Details: Thursday, 26 March 2026 | 9:00 AM – 5:00 PM | Poster – Oral delivery

📍 Booth #39 & Poster Area

Ashland

Ashland offers a broad selection of pharmaceutical excipients to formulate effective pharmaceutical products. Well-kown for cellulosics and acetylenics, Ashland is now also focusing on film coatings and extending its portfolio to injectables and biologics.

Ashland extensive pharma portfolio covers many drug delivery areas including controlled release, film-coatings, binders and disintegrants, bioresorbable polymers for long-acting injectables, lyoprotectants.

📍 Booth #54

Asahi Kasei

Asahi Kasei Europe

Asahi Kasei offers Ceolus™, a microcrystalline cellulose for pharmaceutical and nutraceutical applications, which is highly regarded for its high quality and performance derived from innovative particle morphology.

Ceolus™ guarantees nitrite levels of 0.1 ppm or less in our current primary grades, with test results included in every Certificate of Analysis. The new manufacturing site has been operated since 2023 and they contribute to our clients’ business by providing a stable supply of products.

📅 Session Details: Thursday, 26 March 2026 | 9:00 AM – 5:00 PM | Poster – Oral delivery

📍 Booth #36 & Poster Area

BASF

BASF Pharma Solutions produces innovative excipients and active ingredients of outstanding quality and performance. With a global team of experienced industry specialists and digital solutions, such as the Virtual Pharma Assistants, BASF supports its customers in developing efficient, cost-effective and reliable formulations. Equipped with an in-depth understanding of multiple technologies and applications, BASF has the skills and resources to make drug manufacturing and drug delivery safer and more sustainable.

📍 Booth #58

BENEO

BENEO is part of the Südzucker Group and a member of the International Pharmaceutical Excipients Council (IPEC). BENEO produces galenIQ™ (Isomalt Ph. Eur., USP-NF, JP), which is a water-soluble filler and binder. Derived from beet sugar, galenIQ™ has a sweetness and taste profile very similar to sucrose. Therefore, galenIQ™ is frequently used to improve the palatability of medicine.

The BENEO team will attend ResearchPharm in Prague to discuss the latest developments in pharmaceutical formulation. We will unveil a new scientific poster on the sensory evaluation of isomalt-based chewable tablets, highlighting how excipient selection impacts taste, mouthfeel and patient acceptance.

This year, we are proud to collaborate with KORSCH to demonstrate how advanced excipient characterisation and tablet formulation development can become both efficient and insight-driven. At their booth 21, visitors will discover how the STYL’ONE Nano Benchtop Compaction Simulator supports data-based decision making in early-stage development.
And don’t miss Dr. Michael Black’s speech on the 24th of March from 14:00-14:20 on the topic: How can I make consumer-friendly dosage forms?

📍 Booth #40

BIOGRUND

BIOGRUND specializes in solid oral dosage forms. We develop and produce excellent excipient premixes for film coating, tableting, capsule filling, sugar-coating and coloring. Customized and ready-to-use.

With their own production and sales locations in Germany, Switzerland, USA and Russia, they support their customers worldwide. Their customer-oriented approach offers support from development to production of solid oral dosage forms. Their products make an important contribution to improving oral dosage forms and making them safer and easier to take.

📍 Booth #17

Captisol

Captisol is a derivatized beta cyclodextrin used in 16 FDA-approved products to date, including VEKLURY® (remdesivir) and KYPROLIS® (carfilzomib) to help solubilize & stabilize difficult to deliver molecules. Made by CyDex Pharmaceuticals (a Ligand Company), Captisol is the leading pharmaceutical-grade sulfobutylether beta-cyclodextrin (SBECD), with an excellent record of safety and consistency.

Captisol has been clinically used in therapeutics across many routes of administration, including parenteral, oral, subcutaneous, ophthalmic, nasal, inhalation, and dermal. Increasingly, companies are exploring the benefits of Captisol in consumer health, supplements, and personal care products.

📍 Booth #61

Evonik

Evonik’s Health Care business is an innovation hub for leading global pharmaceutical, medical device and nutraceutical companies. Their broad, versatile portfolio of functional excipients, technologies, and CDMO services for oral and parenteral dosage forms positions us a global leader for advanced drug delivery. They also provide end-to-end CDMO capabilities for small molecule APIs, highly potent APIs and intermediates, and supply high-quality, innovative cell culture solutions. With a trusted global network of manufacturing sites, laboratories, and development centers, they deliver reliable, scalable solutions to more than 1,000 customers worldwide – including 90 percent of the world’s top life-science companies.

📍 Booth #12

Gattefossé

Since 1880, Gattefossé has developed and manufactured high-quality lipid excipients for human and animal health. Their oral excipients offer solubility/bioavailability enhancement, sustained release, lubrication, and taste-masking. They also provide solubilizers, penetration enhancers, emulsifiers, and viscosity enhancers for improved topical formulations, as well as suppository and pessary bases. All Gattefossé products are backed by comprehensive safety, quality, and regulatory documentation to support your formulation and manufacturing needs. To accelerate development, their team of highly trained experts offers hands-on support through four Technical Centers of Excellence located in France, China, India, and the United States.

📅 Session Details: Wednesday, 25 March 2026 | 10:00 – 10:20 | Short talks: Oral route for challenging molecules

📍 Booth #23

Glatt Pharmaceutical Services

Glatt Pharmaceutical Services supports pharmaceutical and biotech companies through every stage of drug product development, from initial formulation design to large-scale commercial manufacturing. With expertise spanning early-stage development, including preclinical and clinical supply production, Glatt ensures seamless scalability while maintaining stringent quality standards. Leveraging advanced technologies like fluidized bed systems, spray granulation, and Wurster coating, Glatt specializes in creating tailored solutions for solubility enhancement, modified release, and other complex drug delivery challenges. Partnering with Glatt means access to end-to-end solutions designed to streamline the path from innovation to market.

📍 Booth #18

IOI Oleo GmbH

IOI Oleo GmbH, a leading manufacturer of vegetable-based oleochemicals, produces lipid-based excipients and APIs for the pharmaceutical market. Manufactured in their EU cGMP-certified and U.S. FDA-approved facility, their sustainable raw materials deliver proven quality and unique performance. Their well-known brands include the MIGLYOL®, WITEPSOL®, SOFTISAN®, IMWITOR® and DYNASAN® product families.

Furthermore, IOI is offering lipid-based tailormade and innovative solutions for pharmaceutical functional excipients, APIs and DDS. The latest outcome of their R&D work are PG-esters as a new group of multi-functional excipients.

📍 Booth #30

JRS Pharma

JRS Pharma is a leading manufacturer of excipients, offering a complete portfolio of solutions for the global pharmaceutical and nutraceutical industries.

Their excipient portfolio includes: high functionality excipients, binders, disintegrants, lubricants, functional fillers, thickeners, stabilizers, gelling agents, carriers and coatings.

📍 Booth #07

Korsch-Medelpharm

KORSCH is a global leader in tableting technology, offering innovative, tailor-made solutions from early R&D to full-scale production, ensuring that each client’s unique needs are met with precision and expertise.

By leveraging their extensive experience in the tableting industry and their deep understanding of production processes, formulators’ needs and technology, MEDELPHARM keeps creating new generations of STYL’One Compaction Simulators to expand possibilities for scientists, offering them the solutions they need to speed up their tableting development. With extensive knowledge gathered by scientists from their INNOVATION CENTERs and Science Lab, they provide support from formulation development to process optimization for all applications.

📍 Booth #21

Lipoid

The Ludwigshafen-based Lipoid Group is the world’s leading supplier for the whole range of high-purity natural, hydrogenated, and synthetic phospholipids.
Naturally derived raw materials and environmentally friendly processes ensure a sustainable supply from renewable sources under highest environmental standards.

Lipoid is globally present with around 500 employees, three production sites and a world-wide distribution organization.
Lipoid’s phospholipids are essential components for state-of-the-art drug delivery systems, such as emulsions, liposomes, lipid nanoparticles, and mixed micelles. They are used in manifold pharmaceutical applications and are suitable for any administration route.

📍 Booth #47

Lonza Capsules & Health Ingredients

Lonza Capsugel is a global leader in capsule design, manufacturing, and encapsulation technology, offering an extensive portfolio of hard empty capsules designed to optimize bioavailability and enhance product performance. Their innovation hub, Innovaform® Accelerator, further enhances their capabilities by providing customized, innovative, capsule solutions for proof-of-concept evaluation. Innovaform® Accelerator supports oral peptide development through formulation development, capsule customization – relying on the award-winning Capsugel® Enprotect® technology platform, targeted-release design, and testing of innovative delivery solutions.

📅 1st Session Details: March 24, 2026 | 10:00 – 10:20 | Short Talk – Site-specific oral delivery system to target the end of the ileum: from capsule design to biorelevant evaluation (Speaker: Elisa Millet)

📅 2nd Session Details: March 26, 2026 | 09:00 – 17:00 | Poster – The influence of different HPMCAS grades for preparation of enteric capsules investigated by MRI and salivary pharmacokinetics in human volunteers (Presenter: Michael Grimm, PhD)

📅 3rd Session Details: March 26, 2026 | 09:00 – 17:00 | Poster – Facilitating encapsulation of permeation enhancers in customized low water permeability enteric capsules (Presenter: Camille Dumont, PhD)

📍 Booth #32, Panorama Hall & Forum Hall Foyer, 2nd Floor (Poster Area)

Lubrizol Life Science

Lubrizol offers an array of pharmaceutical excipients for oral, topical and injectable applications. They combine in-depth understanding of drug delivery systems with a portfolio of specialty materials to provide application-specific solutions to simplify your development process, for both prescription and over-the-counter drug products

📍 Booth #37

MEGGLE Excipients

MEGGLE Excipients is a global leader in manufacturing lactose for the pharmaceutical industry. They offer a broad product portfolio of lactose excipients, coprocessed technologies and excipient contract manufacturing.

MEGGLE is a pioneer in co-processing technologies and developed highly functional excipients possessing unique qualities for directly compressible immediate and sustained release pharmaceutical solid dosage forms.

Meet their experts on-site:
🔹 Ricarda C. Leister, Head of R&D
🔹 Dr. Rebekka Spellerberg, Global Application Manager
🔹 Dr. Karin Hellauer, Innovation Manager

Scientific contributions from MEGGLE Excipients:

📌 Poster Presentation – Case Study: Exploring the Impact of Composition and Process Design on Nitrosamine Formation in Nebivolol Formulations
by Dr. Rebekka Spellerberg

🎤 Oral Short Talk
Lactose polymorphs – processing and characterization by Dr. Karin Hellauer
🗓 26 March | 10:00–11:00
📍 Panorama Hall | Research field: Excipients and Raw Materials

📍 Booth #14 & Panorama Hall

Roquette

Three Legacies United for Better Health

Roquette unites the proven expertise of Roquette Pharma Solutions with the strengths of Qualicaps and IFF Pharma Solutions – bringing together over 75 years of innovation in excipients, APIs, capsules, and drug delivery systems.

They provide comprehensive solutions for controlled release, immediate release, solubility enhancement, and nitrosamine mitigation strategies – leveraging deep polymer expertise, technical excellence, and a strong commitment to sustainable, compliant manufacturing practices.

As a trusted partner and preferred supplier, they help formulators develop robust, high-performing products – faster and more effectively.

At PBP 2026, the company is showcasing its integrated Health and Pharma Solutions (HPS) portfolio, featuring low nitrite excipients for nitrosamine risk mitigation, solubility enhancement strategies for complex molecules, and its new CustomCare® portfolio for 3D-printed pharmaceuticals.

📅 1st Session Details: Tuesday, 24 March 2026 | 15:00 – 15:40 | Invited Talk: Digital evolution in pharma developments: lab data automation and utilization (Speaker: Nicolas Descamps, PhD)

📅 2nd Session Details: Thursday, 26 March 2026 | 11:00 – 11:30 & 13:00 – 15:00 | Scientific Poster Showcase (Forum Hall Foyer):

Integrated In Vitro and In Vivo Characterization of Alginate-Based Anti-Reflux Formulations
Developing Multiple Strengths of Controlled Release (CR) Tablet Formulations
Strategic Formulation of Sustained-Release Matrix Tablets Using METHOCEL™, POLYOX™, and Alginate
Impact of Lubrication and Excipient Ratios in PEARLITOL® CR-H Systems

📍 Booth #24 & Forum Hall Foyer (Poster Area)

Seppic

SEPPIC Human Health Division designs and develops innovative pharmaceutical excipients adapted to oral, topical and parenteral routes of administration. An expert in surfactants, polymers and formulations, Seppic offers ingredients ranging from film-coating agents to powdered solubilizers for tablets, injectable solubilizers and also polymers for dermo-pharmaceuticals. Combining the strength and resources of a large group with the energy and responsiveness of a small company, SEPPIC is equally dedicated to both customer care and product quality.

📍 Booth #20

ShinEtsu

This year, Shin-Etsu celebrates 100 years of production of cellulose derivatives at their site in Japan. Since then, they have expanded their product portfolio to offer multiple solutions for pharmaceutical applications including:

– L-HPC, a dual-functionality excipient that works as binder and disintegran
– PHARMACOAT® and TYLOPUR® (HPMC) as binder for granulation and film coating polymer
– METOLOSE SR® and TYLOPUR® SR(HPMC), hydrophilic matrix agent for sustained release applications
– Shin-Etsu AQOAT® (HPMCAS) and HPMCP, polymers for enteric coating application and solid dispersion

Visit their booth to discuss technical applications of their products.

📍 Booth #15

Zerion Pharma A/S

Zerion Pharma A/S is a pharmaceutical company aspiring to transform the pharmaceutical landscape for the formulation of poorly soluble drugs that are currently not reaching their therapeutic potential.

The company was established in 2019 as a spinout from the University of Copenhagen, based on a decade of research. Zerion Pharma has pioneered the Dispersome® technology that greatly enhances the solubility of poorly soluble, oral drugs and improves bioavailability and therapeutic options for patients.

Through the use of their proprietary Dispersome® formulation platform, they aim to develop new treatment options for patients across all small-molecule therapy areas. They are focused on improving existing drug products by building an internal pipeline, while partnering with originators to enable their early-stage drug molecules, striving to improve the lives of patients around the world.

Their Dispersome®platform is based around a class of novel excipients, namely beta-lactoglobulin (BLG), to formulate poorly soluble small-molecule drugs into stable amorphous drug delivery systems with a high drug load. By increasing solubility and dissolution rate, the Dispersome® platform aims at improving bioavailability and therapeutic outcomes and reducing adverse effects in patients. Dispersome® is well accepted with no safety risks and is compatible with standard solid oral dosage form manufacturing.

📍 Booth #51